CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B309. A total of 34 filers reported holding CAPRICOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,955 | -15.4% | 66,361 | +18.2% | 0.00% | – |
| Q2 2023 | $268,388 | -36.0% | 56,148 | -43.5% | 0.00% | – |
| Q1 2023 | $419,367 | -57.3% | 99,376 | -61.0% | 0.00% | – |
| Q4 2022 | $983,184 | -36.8% | 254,711 | -1.8% | 0.00% | – |
| Q3 2022 | $1,556,000 | +102.9% | 259,438 | +18.0% | 0.00% | – |
| Q2 2022 | $767,000 | +2.1% | 219,852 | +0.4% | 0.00% | – |
| Q1 2022 | $751,000 | +8.4% | 218,907 | -7.4% | 0.00% | – |
| Q4 2021 | $693,000 | -38.1% | 236,338 | -15.2% | 0.00% | – |
| Q3 2021 | $1,119,000 | -3.1% | 278,650 | +23.6% | 0.00% | – |
| Q2 2021 | $1,155,000 | +43.5% | 225,359 | +31.1% | 0.00% | – |
| Q1 2021 | $805,000 | +70.2% | 171,898 | +24.7% | 0.00% | – |
| Q4 2020 | $473,000 | -25.9% | 137,903 | +13.4% | 0.00% | – |
| Q3 2020 | $638,000 | +84.4% | 121,647 | +62.1% | 0.00% | – |
| Q2 2020 | $346,000 | +1135.7% | 75,053 | +214.3% | 0.00% | – |
| Q1 2020 | $28,000 | +86.7% | 23,879 | +109.5% | 0.00% | – |
| Q4 2019 | $15,000 | – | 11,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coastal Bridge Advisors, LLC | 10,894 | $57,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 16,125 | $85,000 | 0.00% |
| Cordasco Financial Network | 310 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 3,727 | $19,000 | 0.00% |
| HAP Trading, LLC | 23,800 | $25,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,943 | $68,000 | 0.00% |
| UBS Group AG | 1,900 | $10,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4,000 | $21,000 | 0.00% |
| US BANCORP \DE\ | 7,462 | $39,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 121 | $1,000 | 0.00% |